12.78 million shares. Find the latest news headlines from Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM) at Nasdaq.com. Why we like ATNM shares at their current price: Tiny float Proprietary, patented technology Late-stage clinical trial ATNM lost -$2.59 per share in the over the last 12 months. BRIEF-Actinium Pharmaceuticals Says Actimab-A Being Studied In A Phase 1 Combination With Bcl-2 Inhibitor In Patients With Relapsed Or Refractory AML 26th Feb '20 News BRIEF-Actinium Presents Positive Findings From Mid-Point Analysis Of Pivotal Sierra Trial Of Iomab-B At 2020 Transplantation & Cellular Therapy Meetings Of ASTCT And CIBMTR actinium pharmaceuticals inc (atnm): * actinium announces completion of enrollment of second dose cohort in actimab-a venetoclax combination trial for patients with r/r aml. The question becomes, what are the chances the stock … Mary Mei Chen has joined the company as Vice President of Clinical Development (news posted on December 1 2020). Explore commentary on Actinium Pharmaceuticals, … View today's stock price, news and analysis for Actinium Pharmaceuticals Inc. (ATNM). Actinium Pharmaceuticals (ATNM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year? Is (ATNM) Outperforming Other Medical Stocks This Year? Actinium Pharmaceuticals has received 63.43% “outperform” votes from our community. Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Actinium Pharmaceuticals News Headlines $7.01-0.17 (-2.37 %) (As of 05/13/2021 12:00 AM ET) Add. Pantginis covers the Healthcare sector, … Email. Actinium Highlights Foundational Patents Covering the Composition of Apamistamab Antibody and Iomab-B Antibody Radiation Conjugate for Targeted Conditioning Until 2037 and Recent EU Patent Activity PR Newswire - PRF - Mon Nov 23, 6:00AM CST ATNM has risen $0.37 from the previous closing price of $8.27 on volume of 286,933 shares. View real-time stock prices and stock quotes for a full financial overview. Headline. Community Sentiment. Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. MORE. Get today's Actinium Pharmaceuticals stock news. Pantginis covers the Healthcare sector, focusing on stocks such as Catabasis Pharmaceuticals, Lineage Cell Therapeutics, and Actinium Pharmaceuticals. Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a … Actinium Pharmaceuticals Inc. [AMEX: ATNM] jumped around 0.03 points on Friday, while shares priced at $0.53 at the close of the session, up 7.45%. 01/20 07:00. So while we can't look to sales to understand growth, we can look at how the cash burn is changing to understand how expenditure is … Also known as ARCs, Antibody Radiation-Conjudates are purported to combine the targeting ability of antibodies with the cell-killing ability of radiation. Sign Up Now Astellas Announces a Research Collaboration with Actinium for Molecular Targeted Radiotherapy. Actinium … MarketBeat's community ratings are surveys of what our community members think about Actinium Pharmaceuticals and other stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Exelixis with a $30.57 average price target, implying a 25.5% upside from current levels. WASHINGTON — U.S. productivity posted a sharp rebound between January and March after falling in the previous quarter. Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Ranked in Earnings Gainer and 1 other category Data delayed 15 minutes. Actinium, Astellas Collaborate on Actinium-225 Based Targeted Radiotherapies Actinium Pharmaceuticals, Inc. has announced the research collaboration with Astellas Pharma… by News Release NEW YORK , March 31, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that it will be participating in the Cell & Gene Meeting on the Mediterranean, which is being held virtually April 6 – 9, 2021, where it will feature its Iomab-ACT program. According to TipRanks.com, Pantginis is a top 25 analyst with an average return of 46.6% and a 66.8% success rate. View today's stock price, news and analysis for Actinium Pharmaceuticals Inc. (ATNM). Get news for AMEX companies quoted on the stock market, press releases, financial disclosures and multimedia content, for investment community, individual investors and the general public. Actinium Pharmaceuticals has received 196 “underperform” votes. A clinical-stage pharmaceutical company, Actinium Pharmaceuticals, Inc. is developing Antibody Radiation-Conjugates. 01/13 07:43. Actinium Pharmaceuticals Estimiated After-Hype Price Volatility In the context of predicting Actinium Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Actinium Pharmaceuticals' historical news … Actinium Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. BRIEF-Actinium Pharmaceuticals Says Actimab-A Being Studied In A Phase 1 Combination With Bcl-2 Inhibitor In Patients With Relapsed Or Refractory AML 26th Feb '20 News BRIEF-Actinium Presents Positive Findings From Mid-Point Analysis Of Pivotal Sierra Trial Of Iomab-B At 2020 Transplantation & Cellular Therapy Meetings Of ASTCT And CIBMTR Astellas to Present Data from Expanding Oncology Portfolio During the 2021 ASCO Annual Meeting. Nymox Pharmaceutical (NASDAQ:NYMX) trades 15.9% down premarket after entering into a definitive agreement with institutional investors in a … Email Sign Up. View which stocks have been most impacted by COVID-19. Email Sign Up. Recent executive movements at Actinium Pharmaceuticals. Actinium Pharmaceuticals Inc (ATNM) stock is up 4.47% while the S&P 500 is lower by -0.47% as of 12:06 PM on Thursday, Mar 25. Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. PR Newswire. Weiter > Weiter > 31.03.21 - PR Newswire Actinium to Participate in the Cell & Gene Meeting on the Mediterranean. ATNM 8.04 0.17 (2.16%). Read More. NEW YORK (AP) — Actinium Pharmaceuticals Inc. (ATNM) on Friday reported a loss of $5.3 million in its first quarter. Actinium Pharmaceuticals Inc. (AMEX: ATNM) is 21.79% higher on its value in year-to-date trading and has touched a low of $4.71 and a high of $19.47 in the current 52-week trading range. When Actinium Pharmaceuticals last reported its balance sheet in December 2020, it had zero debt and cash worth US$64m. von 6. Actinium Pharmaceuticals Inc ATNM ... Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive News. As of July 10, 2020, It … On the Street’s front, the average 12-month analyst price target for the stock is $57.00, marking a 608.96% potential upside from current levels. These ARC’s combine the targeting ability of antibodies with the cell-killing ability of radiation. Actinium Pharmaceuticals, Inc. TRIUMF Enters Collaboration with Fusion Pharmaceuticals to Boost Production of Actinium-225, a Cancer-Fighting Medical Isotope. 50-Day Range. Read More. Share . NEWS -- Actinium Pharmaceuticals Highlights Strong Presence at 59th Annual American Society of Hematology Meeting Evidenced by Clinical Development Progress and Results Showcasing its AWE Technology Platform. Announces Closing Of $31.6 Million Public Offering, Including Full Exercise Of The Underwriters' Option To Purchase Additional Shares … Actinium Pharmaceuticals News < Zurück < Zurück. Receive the latest news, events and updates! William Blair analyst A. Hsieh anticipates that the biotechnology company will post earnings of ($0.29) per share for the quarter. ATNM: Get the latest Actinium Pharmaceuticals stock price and detailed information including ATNM news, historical charts and realtime prices. Actinium Pharmaceuticals News. About Actinium Pharmaceuticals Inc. Actinium Pharmaceuticals, Inc. (Actinium) is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. William Blair also issued estimates for Actinium Pharmaceuticals… Most relevant news about ACTINIUM PHARMACEUTICALS, INC. 05/14: ACTINIUM: Q1 Earnings Snapshot: AQ. Actinium is developing a pipeline of Antibody Radiation Conjugates for targeted conditioning and combination therapies ... SIERRA: Pivotal Phase 3 Clinical Trial of Iomab-B. Actinium Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. We cover the latest Actinium Pharmaceuticals headlines and breaking news impacting Actinium Pharmaceuticals stock performance. $6.92 $7.28. News. Weiter > Weiter > < Zurück < Zurück. Actinium Pharmaceuticals stock news, updates & related news. Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. It engages in the development of novel targeted therapies known as Antibody Radiation-Conjugates (ARCs), … Contact U.S. News Best Stocks. Actinium Pharmaceuticals Inc ATNM Vitals. Actinium, Astellas in research pact for radiotherapies. Average Volume342,816 shs. Actinium’s lead application for its ARC’s is targeted conditioning. $5.22 $19.47. Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that initial patient enrollment in the second dose cohort in the Phase 1 portion of the Actimab-A venetoclax Phase 1/2 combination trial in fit and unfit patients with relapsed or refractory Acute Myeloid Leukemia (r/r AML) has been completed. Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that initial patient enrollment in the second dose cohort in the Phase 1 portion of the Actimab-A venetoclax Phase 1/2 combination trial in fit and unfit patients with relapsed or refractory Acute Myeloid Leukemia (r/r AML) has been completed. The question becomes, what are the chances the stock … ATNM | Complete Actinium Pharmaceuticals Inc. stock news by MarketWatch. Contact Us. Today's Range. Actinium Pharmaceuticals, Inc stock price up 2.16% on Friday (Updated on May 21, 2021) Buy candidate since 2021-05-20 Gain 2.16% PDF . Get the latest Actinium Pharmaceuticals Inc (ATNM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Contact U.S. News Best Stocks. The cancer drug developer posted revenue of $622,000 in the period. News / Therapeutic Area News. View detailed financial information, real-time news, videos, quotes and analysis on Actinium Pharmaceuticals, Inc. (AMEX:ATNM). On a consolidated basis, … The Actinium Pharmaceuticals, Inc stock price gained 2.16% on the last trading day (Friday, 21st May 2021), rising from $7.87 to $8.04. Actinium Pharmaceuticals, Inc. is trading on the NYSE American under the ticker ATNM. Novel Cancer Therapy Phase 3 Trial Expects To Be Completed Shortly 01:07pm, Tuesday, 06'th Apr 2021. NEW YORK (AP) _ Actinium Pharmaceuticals Inc. (ATNM) on Friday reported a loss of $5.3 million in its first quarter. In 1939, Perey noted that actinium she had obtained by fractional precipitation of uranium ore emitted an unexpected type of radiation. The New York-based company said it had a loss of 29 cents per share. Company Name: Actinium Pharmaceuticals Inc., Stock Symbol: ATNM, Industry: Biotechs, Total Posts: 2565, Last Post: 5/21/2021 8:49:04 AM Actinium (CURRENCY:ACM) traded 0.8% lower against the US dollar during the 1-day period ending at 19:00 PM E.T. The company report on June 19, 2020 that Actinium Pharmaceuticals, Inc. Receive the latest news, events and updates! Labor costs declined slightly. Find out why Actinium Pharmaceuticals's (ATNM) news sentiment is more negative in … Together, we can accelerate the development of pharmaceuticals using actinium-225 and bring this material to patients in need of life-saving cancer therapy. Stock analysis for Actinium Pharmaceuticals Inc (ATNM:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Contact Us. When share has gained more than 10% since it's last Earning release, it tends to over react to minor bad news and give up some gains if not all. The latest news and upcoming dividend, earnings, and split events for Actinium Pharmaceuticals Inc. (Delaware) (ATNM:US). Actinium Pharmaceuticals (NYSE: ATNM) Trending Biopharma Stock. Contact. Current price $10.84 per share (Friday’s close) Outstanding shares (est.) Ranked in Earnings Gainer and 1 other category Data delayed 15 minutes. The New York-based company … PR … Looking at the last year, the company burnt through US$22m. The panel discussion included Steve O’Loughlin, CFO of Actinium Pharmaceuticals Inc (NYSE: ATNM), Bill Williams, ... Everything you need to know about the latest SPAC news. Compare. Productivity increased at an annual rate of 5.4% in the first quarter, recovering from a 3.8% rate of decline in the fourth quarter of last year, the Labor Department reported Thursday. Actinium Pharmaceuticals (NYSE:ATNM) is a clinical stage biotech developing treatments in the growing field of targeted radiotherapies. Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) – Analysts at William Blair issued their Q1 2022 EPS estimates for Actinium Pharmaceuticals in a research report issued on Monday, May 17th. ATNM, Actinium Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Actinium Pharmaceuticals Stock Quote: ATNM Stock News, Quotes, Analysis | Investors.com Actinium Pharmaceuticals Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.
Factset Recruitment Process 2021, Implied Volatility Td Ameritrade, Negative Impact Of School Closure, Can Each Netflix Profile Have A Password, How To Make Netflix Powerpoint Presentation, Facts About Andriyan Nikolayev, California Background Check, What Happened To Silver In Gotham, Apriltag: A Robust And Flexible Visual Fiducial System,